Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Abbott Obtains FDA Nod for TactiFlex Duo Ablation Catheter

9 September 2026 · By · Wire by Fusion42

Published

9 September 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at mddionline.com →

◆ Verified

Fusion42 · 9 September 2026 · Fusion42 review

Abbott has received FDA approval for its TactiFlex Duo ablation catheter, enabling its use in cardiovascular procedures in the United States.

This Wire brief sits within Fusion42's coverage of Medtech, and 4 sources have reported it between 8 Sep 2026 and 9 Sep 2026.

◆ ◆ The Wire takeaway

Cardiovascular device startups face a clearer pathway for catheter ablation products in the US after Abbott's FDA approval. You can now explore faster market entry and competitive positioning in ablation tech.

◆ Coverage

4 sources · first reported 8 Sep 2026 · latest 9 Sep 2026

◆ Related on Wire

◆ Topics

MedtechFDA-approvalablation-cathetercardiovascularmedical-deviceAbbott